» Articles » PMID: 17169370

Crystal Structure of Human Cyclin K, a Positive Regulator of Cyclin-dependent Kinase 9

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2006 Dec 16
PMID 17169370
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclin K and the closely related cyclins T1, T2a, and T2b interact with cyclin-dependent kinase 9 (CDK9) forming multiple nuclear complexes, referred to collectively as positive transcription elongation factor b (P-TEFb). Through phosphorylation of the C-terminal domain of the RNA polymerase II largest subunit, distinct P-TEFb species regulate the transcriptional elongation of specific genes that play central roles in human physiology and disease development, including cardiac hypertrophy and human immunodeficiency virus-1 pathogenesis. We have determined the crystal structure of human cyclin K (residues 11-267) at 1.5 A resolution, which represents the first atomic structure of a P-TEFb subunit. The cyclin K fold comprises two typical cyclin boxes with two short helices preceding the N-terminal box. A prominent feature of cyclin K is an additional helix (H4a) in the first cyclin box that obstructs the binding pocket for the cell-cycle inhibitor p27(Kip1). Modeling of CDK9 bound to cyclin K provides insights into the structural determinants underlying the formation and regulation of this complex. A homology model of human cyclin T1 generated using the cyclin K structure as a template reveals that the two proteins have similar structures, as expected from their high level of sequence identity. Nevertheless, their CDK9-interacting surfaces display significant structural differences, which could potentially be exploited for the design of cyclin-targeted inhibitors of the CDK9-cyclin K and CDK9-cyclin T1 complexes.

Citing Articles

Prognostic Evaluation and Functional Characterization of Cyclin K Expression in Endometrial Cancer: Immunohistochemical and In Silico Analysis.

Szymanski M, Bonowicz K, Jerka D, Gagat M, Antosik P Cancers (Basel). 2025; 17(5).

PMID: 40075638 PMC: 11898804. DOI: 10.3390/cancers17050792.


Structure-independent machine-learning predictions of the CDK12 interactome.

Karolak A, Urbaniak K, Monastyrskyi A, Duckett D, Branciamore S, Stewart P Biophys J. 2024; 123(17):2910-2920.

PMID: 38762754 PMC: 11393676. DOI: 10.1016/j.bpj.2024.05.017.


Coming of Age: Targeting Cyclin K in Cancers.

Xiao Y, Dong J Cells. 2023; 12(16).

PMID: 37626854 PMC: 10453554. DOI: 10.3390/cells12162044.


The Prognostic Role of CDK9 in Bladder Cancer.

Borowczak J, Szczerbowski K, Maniewski M, Zdrenka M, Slupski P, Antosik P Cancers (Basel). 2022; 14(6).

PMID: 35326643 PMC: 8945910. DOI: 10.3390/cancers14061492.


Kinases: Understanding Their Role in HIV Infection.

De Martini W, Rahman R, Ojegba E, Jungwirth E, Macias J, Ackerly F World J AIDS. 2020; 9(3):142-160.

PMID: 32257606 PMC: 7118713. DOI: 10.4236/wja.2019.93011.


References
1.
Terwilliger T, Berendzen J . Automated MAD and MIR structure solution. Acta Crystallogr D Biol Crystallogr. 1999; 55(Pt 4):849-61. PMC: 2746121. DOI: 10.1107/s0907444999000839. View

2.
Perrakis A, Morris R, Lamzin V . Automated protein model building combined with iterative structure refinement. Nat Struct Biol. 1999; 6(5):458-63. DOI: 10.1038/8263. View

3.
Jung J, Kim S . Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6. Structure. 1999; 7(3):245-54. DOI: 10.1016/s0969-2126(99)80035-5. View

4.
Brown N, Noble M, Endicott J, Johnson L . The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat Cell Biol. 1999; 1(7):438-43. DOI: 10.1038/15674. View

5.
Fu T, Peng J, Lee G, Price D, Flores O . Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription. J Biol Chem. 1999; 274(49):34527-30. DOI: 10.1074/jbc.274.49.34527. View